ARWR Arrowhead Pharmaceuticals, Inc.
Healthcare$76.68+0.00%OpenMarket Cap: $10.80B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$83.56
Target (Median)
$90.00
Target Range
$35.00 - $110.00
Upside from current price: 9.0%
Rating Distribution
4 Strong Buy7 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-13 | Bernstein | maintain | Market Perform | Market Perform |
| 2026-05-08 | RBC Capital | maintain | Outperform | Outperform |
| 2026-04-21 | Morgan Stanley | upgrade | Overweight | Equal Weight |
| 2026-03-25 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-10 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-01-22 | B. Riley Securities | maintain | Buy | Buy |
| 2026-01-13 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-01-07 | Goldman Sachs | maintain | Neutral | Neutral |
| 2026-01-07 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| 2026-01-07 | Chardan Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Sep 30 | $-3.90 | $353.3M | 10 |
| Sat Sep 30 | $-2.83 | $601.2M | 9 |
| Sun Sep 30 | $-1.63 | $876.6M | 6 |
| Mon Sep 30 | $2.47 | $1.59B | 7 |